Abstract
No public abstract is available from the verified source records.
Mu Seog Choe, Woo Sub Yang, Bilal Cakir, Ferdi Ridvan Kiral, Jonghun Kim, Cynthia Lo, Eena Cheng, Benjamin Ongnok, Viswanathan Muthusamy, In-Hyun Park
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021
10.1093/neuonc/noae145 · 2024
Advances in Glioblastoma Therapy: An Update on Current Approaches
10.3390/brainsci13111536 · 2023
Survival prediction in glioblastoma: 10-year follow-up from the Dutch Neurosurgery Quality Registry
10.1007/s11060-025-05080-3 · 2025
Radiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional results
10.1371/journal.pone.0078943 · 2013
Emerging Cellular Therapies for Cancer
10.1146/annurev-immunol-042718-041407 · 2019
CAR T cell immunotherapy for human cancer
10.1126/science.aar6711 · 2018
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012-2023)
10.1080/21645515.2024.2338984 · 2024
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
10.1001/jamaoncol.2017.0184 · 2017
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
10.1056/nejmoa1610497 · 2016
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
2017
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
10.1056/nejmoa2314390 · 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Ralpha2 in recurrent glioblastoma: phase 1 trial interim results
10.1038/s41591-024-02893-z · 2024
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors (vol 24, pg 1459, 2018)
10.1038/s41591-019-0355-0 · 2019
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
10.1158/1078-0432.ccr-17-1846 · 2018
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma
10.1038/s41591-019-0694-x · 2020
The complex role of tumor-infiltrating macrophages
10.1038/s41590-022-01267-2 · 2022
Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages
10.1093/carcin/bgs387 · 2013
The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients
2003
Targeting inflammation with chimeric antigen receptor macrophages using a signal switch
10.1038/s41551-025-01387-8 · 2025
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers
10.1007/s00262-024-03759-6 · 2024
Human chimeric antigen receptor macrophages for cancer immunotherapy
10.1038/s41587-020-0462-y · 2020
A second-generation M1-polarized CAR macrophage with antitumor efficacy
10.1038/s41590-023-01687-8 · 2024
Role of microglia in glioma biology
10.1002/jemt.1125 · 2001
Microglia function in brain tumors
10.1002/jnr.20485 · 2005
Review: Molecular mechanism of microglia stimulated glioblastoma invasion
10.1016/j.matbio.2013.07.008 · 2013
Microglia phagocytic mechanisms: Development informing disease
10.1016/j.conb.2024.102877 · 2024
Phagocytosis of microglia in the central nervous system diseases
10.1007/s12035-013-8620-6 · 2014
The Role of Microglia in Glioblastoma
2020
Expression of the transcription factor PU.1 induces the generation of microglia-like cells in human cortical organoids
10.1038/s41467-022-28043-y · 2022
Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo
10.1038/s41593-020-00730-3 · 2020
An in vivo neuroimmune organoid model to study human microglia phenotypes
10.1016/j.cell.2023.04.022 · 2023
Genetic mutation patterns among glioblastoma patients in the Taiwanese population - insights from a single institution retrospective study
10.1038/s41417-024-00746-y · 2024
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in -Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
10.1158/1078-0432.ccr-17-0890 · 2017
Microglia in the cerebral wall of the human telencephalon at second trimester
10.1093/cercor/bhh194 · 2005
ATP mediates rapid microglial response to local brain injury in vivo
10.1038/nn1472 · 2005
Fcγ receptor signaling in primary human microglia:: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction
10.1189/jlb.0403128 · 2004
Chimeric antigen receptors that trigger phagocytosis
10.7554/elife.36688 · 2018
EGFRVIII and EGFR targeted chimeric antigen receptor T cell therapy in glioblastoma
10.3389/fonc.2024.1434495 · 2024
Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications
10.1155/2017/7403747 · 2017
Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM
2022
A simple metastatic brain cancer model using human embryonic stem cell-derived cerebral organoids
10.1096/fj.202000372r · doi-reference
The single-cell transcriptional landscape of mammalian organogenesis
10.1038/s41586-019-0969-x · doi-reference
Integrated analysis of multimodal single-cell data
10.1016/j.cell.2021.04.048 · doi-reference
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
10.1038/s43018-023-00709-6 · doi-reference
Armored bicistronic CAR T cells with dominant-negative TGF-beta receptor II to overcome resistance in glioblastoma
10.1016/j.ymthe.2024.07.020 · doi-reference
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
10.1136/jitc-2022-006239 · doi-reference
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
10.1038/s41467-020-20599-x · doi-reference
Information processing during phagocytosis
10.1038/nri3244 · doi-reference
Signaling pathways in phagocytosis
10.1002/(sici)1521-1878(199905)21:5<422::aid-bies9>3.0.co;2-# · doi-reference
CAR-T cell therapy: current limitations and potential strategies
10.1038/s41408-021-00459-7 · doi-reference
Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
10.1158/2159-8290.cd-20-0556 · doi-reference
Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
10.1016/j.canlet.2018.01.050 · doi-reference
The MHC class I-LILRB1 signalling axis as a promising target in cancer therapy
10.1111/sji.12804 · doi-reference
Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 “Don't Eat Me” Signals
10.1158/1078-0432.ccr-14-2520 · doi-reference
Microglia in Glioblastomas: Molecular Insight and Immunotherapeutic Potential
10.3390/cancers16111972 · doi-reference